[Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
V G
VG
Kucherianu
G N
GN
Kryzhanovskiĭ
V S
VS
Kudrin
V V
VV
Iurasov
E V
EV
Nikushkin
I V
IV
Zhigal'tsev
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000281:Administration, Intranasal; D000375:Aging / Q000502:physiology; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents; D016220:Fibroblast Growth Factor 1 / Q000008:administration & dosage / Q000494:pharmacology*; D006719:Homovanillic Acid / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009127:Muscle Rigidity / Q000503:physiopathology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology
D015259:Dopamine Agents; D015102:3,4-Dihydroxyphenylacetic Acid; D016220:Fibroblast Growth Factor 1; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine; D006719:Homovanillic Acid
Vliianie kislogo faktora rosta fibroblastov na razvitie éksperimental'nogo parkinsonizma i uroven' dofamina i ego metabolitov v striatume mysheĭ raznogo vozrasta.